Feature|Articles|August 20, 2025
- Pharmaceutical Executive: August 2025
- Volume 45
- Issue 6
2025 Emerging Pharma Leaders
Author(s)Mike Hollan
Listen
0:00 / 0:00
Pharm Exec unveils its new slate of rising leaders in the biopharma industry—profiling the stories of five executives steering innovative scientific and strategic pursuits in R&D, market access, and patient support.
Advertisement
Follow the links below to read about each selection:
(In alphabetical order)
*These five individuals were chosen from a pool of nominations by the Pharmaceutical Executive Editorial staff. Selections were based on a number of criteria and review of professional accomplishments and progression of responsibilities in line with those executives inhabiting key “c-suite” functions.
Articles in this issue
9 months ago
The CAR-T Climb9 months ago
An RNA-Guided Path9 months ago
Acceleration and Ambition9 months ago
Driving Disruption in Delivery9 months ago
Building Promise from Precision9 months ago
Determined Problem-Solver9 months ago
How to Get Product Iteration Right in HealthcareAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates
3
FDA Approves Baxdrostat for Uncontrolled Hypertension in First-in-Class Entry
4
How Pharma is Adjusting Strategies for Changing Dynamics at FDA
5